Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes.
about
Membrane bioprocesses for pharmaceutical micropollutant removal from watersHidden drivers of low-dose pharmaceutical pollutant mixtures revealed by the novel GSA-QHTS screening methodGene-class analysis of expression patterns induced by psychoactive pharmaceutical exposure in fathead minnow (Pimephales promelas) indicates induction of neuronal systems.Prioritizing environmental risk of prescription pharmaceuticalsPhotolytic and thin TiO₂ film assisted photocatalytic degradation of sulfamethazine in aqueous solution.Removal and seasonal variability of selected analgesics/anti-inflammatory, anti-hypertensive/cardiovascular pharmaceuticals and UV filters in wastewater treatment plant.Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluentsPsychoactive pharmaceuticals induce fish gene expression profiles associated with human idiopathic autismAerobic degradation of ibuprofen in batch and continuous reactors by an indigenous bacterial community.Pharmaceutical Residues Affecting the UNESCO Biosphere Reserve Kristianstads Vattenrike Wetlands: Sources and SinksOccurrence and preliminarily environmental risk assessment of selected pharmaceuticals in the urban rivers, China.A risk-based approach to managing active pharmaceutical ingredients in manufacturing effluent.Ecotoxicological risk assessment and seasonal variation of some pharmaceuticals and personal care products in the sewage treatment plant and surface water bodies (lakes).Identification and assessment of ecotoxicological hazards attributable to pollutants in urban wet weather discharges.Algal cultivation in urban wastewater: an efficient way to reduce pharmaceutical pollutants.Do pharmaceuticals reach and affect the aquatic ecosystems in Brazil? A critical review of current studies in a developing country.LC-QTOF MS screening of more than 1,000 licit and illicit drugs and their metabolites in wastewater and surface waters from the area of Bogotá, Colombia.Monitoring pharmaceuticals and personal care products in reservoir water used for drinking water supply.Tracking multiple modes of endocrine activity in Australia's largest inland sewage treatment plant and effluent- receiving environment using a panel of in vitro bioassays.Effects of contaminants of emerging concern on Megaselia scalaris (Lowe, Diptera: Phoridae) and its microbial community.Phthalate esters in water and surface sediments of the Pearl River Estuary: distribution, ecological, and human health risks.Cleanup strategies and advantages in the determination of several therapeutic classes of pharmaceuticals in wastewater samples by SPE-LC-MS/MS.Monitoring the presence of 13 active compounds in surface water collected from rural areas in northwestern Spain.Occurrence of pharmaceuticals in urban wastewater of north Indian cities and risk assessment.Occurrence of selected pharmaceuticals in the principal sewage treatment plants in Rome (Italy) and in the receiving surface waters.Monitoring of emerging pollutants in Guadiamar River basin (South of Spain): analytical method, spatial distribution and environmental risk assessment.Toxicity of 8-Hydroxyquinoline in Cryprinus carpio Using the Acute Toxicity Test, Hepatase Activity Analysis and the Comet Assay.Occurrence of selected pharmaceuticals in water and sediment of Umgeni River, KwaZulu-Natal, South Africa.Magnetic microsphere-based portable solid phase extraction device for on-site pre-concentration of organics from large-volume water samples.Tracing the limits of organic micropollutant removal in biological wastewater treatment.Effects of mixture of pharmaceuticals on early life stages of tench (Tinca tinca).Occurrence of enrofloxacin in overflows from animal lot and residential sewage lagoons and a receiving-stream.Pharmaceutical factories as a source of drugs in water.The synthetic gestagen Levonorgestrel disrupts sexual development in Xenopus laevis by affecting gene expression of pituitary gonadotropins and gonadal steroidogenic enzymes.Ecotoxicity and environmental risk assessment of pharmaceuticals and personal care products in aquatic environments and wastewater treatment plants.Sorption and cosorption of lead and sulfapyridine on carbon nanotube-modified biochars.Identification of biotransformation products of macrolide and fluoroquinolone antimicrobials in membrane bioreactor treatment by ultrahigh-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.Occurrence of pharmaceuticals in municipal wastewater, in the recipient water, and sedimented particles of northern Lake Päijänne.Occurrence of endocrine disrupters and selected pharmaceuticals in Aisonas River (Greece) and environmental risk assessment using hazard indexes.Reaction of β-blockers and β-agonist pharmaceuticals with aqueous chlorine. Investigation of kinetics and by-products by liquid chromatography quadrupole time-of-flight mass spectrometry.
P2860
Q27000817-1F52A38F-BC1D-4A01-8CD7-3A43B0CE2F17Q28831097-FB509692-38FC-4DEE-A97F-3383AC931833Q30459493-39B27000-6D1B-474B-9168-4F62A7A89F4BQ30670807-EBBB117F-9176-43EC-B047-0B982BE20373Q30916531-627F82B7-499D-4AA6-B90B-4AF52A06A15AQ31153546-71D891B9-088B-43BD-87F0-EE731707F033Q33947011-D4F1F226-07B9-4DFD-8A91-8631252B1328Q34305076-A56540D4-2A9F-42C9-8ADE-E4B9BD332E8CQ35932304-B67EAEA2-E4BC-4AE7-8ED6-55AD7837CEE8Q37239504-B6CCE60B-74A5-400C-8BAD-2BD14EB64ED4Q37319874-CC0CE518-E2D0-44F0-81C8-1C510117FDEBQ38548895-4C57F264-816D-4627-A3D3-6FA2AB3FBA34Q38629380-FA2EBB29-4229-43AC-81BC-FB01459B3B86Q38660392-B556A01F-A72B-4540-A56F-0317D875209BQ38875276-D05BCFC8-44C2-447C-B887-8FEE76FB96DDQ38979288-F28D8DDE-87CF-46AE-AA4B-29387B5A3C3EQ38994703-74A1B6F8-07CC-405F-A855-D92A0936A7ECQ39010892-D2CF05AF-9157-4CF6-AF05-4F2A6DA19B8AQ39011042-37E10412-45F3-4BB0-A985-71CCEF2FFC96Q39348413-D264FD04-9EA6-41AC-A2A4-B1D054CC5A60Q39637636-A96DAC05-EF71-4992-8F20-CC6B19842B23Q39955315-D8011F14-5316-40EE-838E-05AF56B0ABD6Q40191997-3C4963D7-4C22-40E4-944A-D6DC61195AFEQ40206189-37EBEBDA-1C10-4EFD-9F1A-AF4EF96570E7Q40231461-ABE4EF59-0BB5-45A1-B4EB-7F1D3FE072C5Q40408566-56B3A542-85B0-47A2-9B32-21636249410CQ40843123-F096C198-E115-4DF8-B22A-0FA89B8E512AQ41362453-4C87FAE6-01BA-4A68-89C1-9BBC43B4C3A2Q41388755-8C4B0632-B68C-4ED1-8A56-E444854BE09BQ41482324-F6B060B5-2C93-436E-A174-00FC1A93E689Q42181466-D876C2AA-C14E-43D7-A6BA-17F61007EFF3Q42374642-C2EF5D87-00ED-4B5C-809D-44BF93995D22Q42422318-1C5D7576-A7E3-4558-AAAF-9CAB89E62343Q42726889-4C7254C2-B953-4D6A-A07F-ABC8831099EAQ43320644-F1F100F2-37F8-4B77-B3CE-1420EE54ED80Q43323038-3743B693-A332-4BCC-A01B-2A8B48E158E2Q43329584-72C54C6D-6405-4ABE-A36D-7D79599D72F9Q43335420-91AD42EC-7F53-4B6C-8163-0860B1406B96Q43337009-DDDEE53D-BEC0-4F1A-92F8-64BDEADC6A5AQ43339868-F38C7A9A-9A81-4E2E-9D28-C8A06DCBB83C
P2860
Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Removal of pharmaceuticals dur ...... sessment using hazard indexes.
@en
Removal of pharmaceuticals dur ...... sessment using hazard indexes.
@nl
type
label
Removal of pharmaceuticals dur ...... sessment using hazard indexes.
@en
Removal of pharmaceuticals dur ...... sessment using hazard indexes.
@nl
prefLabel
Removal of pharmaceuticals dur ...... sessment using hazard indexes.
@en
Removal of pharmaceuticals dur ...... sessment using hazard indexes.
@nl
P1476
Removal of pharmaceuticals dur ...... ssessment using hazard indexes
@en
P2093
Damià Barceló
Meritxell Gros
P356
10.1016/J.ENVINT.2009.09.002
P577
2009-10-12T00:00:00Z